MetaCap

AnaptysBio Inc. Company Profile

NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.63-0.77 (-1.62%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AnaptysBio at a glance

AnaptysBio Inc. (NASDAQ: ANAB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA. AnaptysBio is led by Mr. Daniel R. Faga. The company's shares have traded publicly since 2017.

At a market capitalization of $1.41 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001370053, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does AnaptysBio do?

AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States. The company manages financial collaborations for Jemperli, a PD-1 antagonist for various solid tumor indications; and Quimilza, an IL-36R antagonist mAb, which has completed two registration-enabling global Phase 3 trials, and GEMINI-1 and GEMINI-2, evaluating the safety and efficacy of Quimilza in patients with generalized pustular psoriasis. It has a collaboration and exclusive license agreement with GSK plc to develop Jemperli as a monotherapy; and an exclusive license agreement with Vanda Pharmaceuticals Inc. for the development and commercialization of Quimilza. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
AnaptysBio Inc.
Ticker
NASDAQ: ANAB
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Daniel R. Faga
Headquarters
10770 Wateridge Circle, San Diego, CA, United States
Phone
858 362 6295
IPO year
2017
SEC CIK
0001370053
Latest annual report
10-K/A · Apr 28, 2026

Companies similar to AnaptysBio

ANAB peer companies
CompanyPrice% ChgMarket capCompare
NRIXNurix Therapeutics Inc.12.85-5.55%$1.40Bvs ANAB
ADRXADARx Pharmaceuticals Inc.12.79-9.68%$1.42Bvs ANAB
TYRATyra Biosciences Inc.20.12+1.98%$1.39Bvs ANAB
SRPTSarepta Therapeutics Inc.13.33-5.93%$1.43Bvs ANAB
KLRAKailera Therapeutics Inc.11.02-4.84%$1.43Bvs ANAB
DMRADamora Therapeutics Inc.23.22-4.44%$1.44Bvs ANAB
RAPPRapport Therapeutics Inc.23.16-1.82%$1.37Bvs ANAB
QUREuniQure N.V.19.35-4.35%$1.36Bvs ANAB

Related